Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging

Show other versions (1)

The neural substrate underlying cognitive impairments after chemotherapy is largely unknown. Here, we investigated very late (>9 years) effects of adjuvant high-dose chemotherapy on brain white and gray matter in primary breast cancer survivors (n = 17) with multimodal magnetic resonance imag...

Bibliografske podrobnosti
Main Authors:	De Ruiter, M, Reneman, L, Boogerd, W, Veltman, D, Caan, M, Douaud, G, Lavini, C, Linn, S, Boven, E, Van Dam, F, Schagen, S
Format:	Journal article
Jezik:	English
Izdano:	2012

Podobne knjige/članki

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging.
od: de Ruiter, M, et al.
Izdano: (2012)

Adjuvant chemotherapy: an autoethnography
od: Greenhalgh, T
Izdano: (2017)

Adjuvant chemotherapy for colorectal cancer.
od: Kerr, D, et al.
Izdano: (1996)

The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling.
od: Gaffney, E
Izdano: (2004)

The survivor : Bill Clinton in the White House /
od: Harris, John F. (John Furby), 1963-
Izdano: (2005)

Adjuvant treatment for colorectal cancer. Concerns about chemotherapy are legitimate.
od: Gray, R, et al.
Izdano: (1996)

Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
od: Midgley, R, et al.
Izdano: (2005)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
od: Teoh, S, et al.
Izdano: (2018)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
od: Findlay, J, et al.
Izdano: (2016)

VATS lobectomy facilitates delivery of adjuvant chemotherapy following NSCLC resection
od: Abah, U, et al.
Izdano: (2012)

Chemotherapy for colorectal cancer in the metastatic and adjuvant setting: past, present and future.
od: Sabharwal, A, et al.
Izdano: (2007)

Cognitive function in women with early breast cancer receiving adjuvant chemotherapy
od: Lacey, RT, et al.
Izdano: (2006)

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
od: Gray, R, et al.
Izdano: (2007)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
od: Teoh, S, et al.
Izdano: (2016)

Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model.
od: Zerbi, V, et al.
Izdano: (2013)

Plasticity in gray and white: Neuroimaging changes in brain structure during learning
od: Zatorre, R, et al.
Izdano: (2012)

Plasticity in gray and white: neuroimaging changes in brain structure during learning.
od: Zatorre, R, et al.
Izdano: (2012)

Long-term cerebral white and gray matter changes after preeclampsia
od: Siepmann, T, et al.
Izdano: (2017)

Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
od: Midgley, R, et al.
Izdano: (2005)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
od: Midgley, R, et al.
Izdano: (2013)

The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics.
od: Gaffney, E
Izdano: (2005)

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
od: Campbell, H, et al.
Izdano: (2011)

The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses
od: Campbell, H, et al.
Izdano: (2011)

Brain white and gray matter anatomy of MRI segmentation based on tissue evaluation
od: Salih, Qussay Abbas, et al.
Izdano: (2005)

Epithelial‐to‐mesenchymal transition (EMT) to sarcoma in recurrent lung adenosquamous carcinoma following adjuvant chemotherapy
od: Poh, Mau Ern, et al.
Izdano: (2019)

Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues
od: Van Gool, I, et al.
Izdano: (2018)

Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy
od: Prasad, U., et al.
Izdano: (2002)

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
od: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Izdano: (2008)

Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes
od: Nouwen, A, et al.
Izdano: (2013)

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.
od: Gelineau-Morel, R, et al.
Izdano: (2012)

Author response: Long-term cerebral white and gray matter changes after preeclampsia
od: Siepmann, T, et al.
Izdano: (2017)

SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI
od: Battaglini, M, et al.
Izdano: (2017)

White matter hyperintensity segmentation on brain images using modified gray level technique /
od: Sarah Samson Soh, 1987-, author 618813, et al.
Izdano: (2018)

White matter hyperintensity segmentation on brain images using modified gray level technique /
od: Sarah Samson Soh, 1987-, author 618813
Izdano: (2018)

Eileen Gray /
od: 342671 Constant, Caroline
Izdano: (2000)

Dwelling in the gray /
od: 374436 Harvey, Clay
Izdano: (2000)

Topical mitomycin-C as an adjuvant to multimodal endoscopic treatment for tracheobronchial stenosis secondary to endobronchial tuberculosis
od: Huan, Nai‐Chien, et al.
Izdano: (2021)

Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
od: Isaac, N, et al.
Izdano: (2002)

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
od: Gray, R, et al.
Izdano: (2004)

The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
od: Sobrero, A, et al.
Izdano: (2019)